Department of General Surgery, PLA General Hospital, Beijing, China.
PLoS One. 2013;8(2):e55532. doi: 10.1371/journal.pone.0055532. Epub 2013 Feb 5.
Transforming growth factor (TGF)-β/Smad signaling plays an important role in colon cancer development, progression and metastasis. In this study we demonstrated that the microRNA-130a/301a/454 family is up-regulated in colon cancer tissues compared to paired adjacent normal mucosa, which share the same 3'-untranslational region (3'-UTR) binding seed sequence and are predicated to target Smad4. In colorectal cancer HCT116 and SW480 cells, overexpression of miRNA-130a/301a/454 mimics enhances cell proliferation and migration, while inhibitors of these miRNAs affect cell survival. The biological function of miRNA-130a/301a/454 on colon cancer cells is likely mediated by suppression of Smad4, and the up-regulation of the miRNAs is correlated with Smad4 down-regulation in human colon cancers. Collectively, these results suggest that miRNA-130a/301a/454 are novel oncogenic miRNAs contributing to colon tumorigenesis by regulating TGF-β/Smad signaling, which may have potential application in cancer therapy.
转化生长因子-β(TGF-β)/Smad 信号通路在结肠癌的发生、发展和转移中起着重要作用。本研究表明,与配对的相邻正常黏膜相比,结肠癌组织中 microRNA-130a/301a/454 家族上调,它们共享相同的 3'非翻译区(3'UTR)结合种子序列,并预测靶向 Smad4。在结直肠癌细胞 HCT116 和 SW480 中,miRNA-130a/301a/454 的过表达模拟物增强细胞增殖和迁移,而这些 miRNA 的抑制剂影响细胞存活。miRNA-130a/301a/454 对结肠癌细胞的生物学功能可能是通过抑制 Smad4 介导的,并且 miRNA 的上调与人类结肠癌中 Smad4 的下调相关。综上所述,这些结果表明,miRNA-130a/301a/454 是新型致癌 miRNA,通过调节 TGF-β/Smad 信号通路促进结肠癌发生,可能在癌症治疗中有潜在应用。